Media coverage
1
Media coverage
Title The competition's heating up over a $35 billion market to treat NASH, a 'silent disease' millions are living with. But the early results look mixed. Media name/outlet Business Insider UK Country/Territory United Kingdom Date 19/02/19 URL https://www.businessinsider.com/nash-liver-disease-drug-development-links-to-genetics-and-microbiome-2018-4?r=UK&IR=T Persons Scott Friedman